eLife (Oct 2015)

Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs

  • Eva Malatinkova,
  • Ward De Spiegelaere,
  • Pawel Bonczkowski,
  • Maja Kiselinova,
  • Karen Vervisch,
  • Wim Trypsteen,
  • Margaret Johnson,
  • Chris Verhofstede,
  • Danny de Looze,
  • Charles Murray,
  • Sabine Kinloch-de Loes,
  • Linos Vandekerckhove

DOI
https://doi.org/10.7554/eLife.09115
Journal volume & issue
Vol. 4

Abstract

Read online

Persistent reservoirs remain the major obstacles to achieve an HIV-1 cure. Prolonged early antiretroviral therapy (ART) may reduce the extent of reservoirs and allow for virological control after ART discontinuation. We compared HIV-1 reservoirs in a cross-sectional study using polymerase chain reaction-based techniques in blood and tissue of early-treated seroconverters, late-treated patients, ART-naïve seroconverters, and long-term non-progressors (LTNPs) who have spontaneous virological control without treatment. A decade of early ART reduced the total and integrated HIV-1 DNA levels compared with later treatment initiation, but not reaching the low levels found in LTNPs. Total HIV-1 DNA in rectal biopsies did not differ between cohorts. Importantly, lower viral transcription (HIV-1 unspliced RNA) and enhanced immune preservation (CD4/CD8), reminiscent of LTNPs, were found in early compared to late-treated patients. This suggests that early treatment is associated with some immunovirological features of LTNPs that may improve the outcome of future interventions aimed at a functional cure.

Keywords